Manufacturer record
Orchid Medilife Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Orchid Medilife Pvt. Ltd (Himachal Pradesh) was declared Not of Standard Quality in February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TD250606, Zinc Acetate Dispersible Tablets 20 mg (exp Mar 2027). RDTL, Guwahati (CDSCO lab) found it not of standard quality: The sample is not of standard quality for the reason stated under Description of the tablets. Listed in the February 2026 alert.
Records by type
1 record linked to Orchid Medilife Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Zinc Acetate Dispersible Tablets 20 mg | Batch TD250606Mfg Apr 2025 · Exp Mar 2027 | The sample is not of standard quality for the reason stated under Description of the tablets.Description | RDTL, GuwahatiCDSCO lab | Feb 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.